Projekt

Thoracic radiotherapy plus maintenance Durvalumab after first line Carboplatin and Etoposide plus Durvalumab in extensive-stage disease small cell lung cancer (ED-SCLC) A multicenter single arm open label phase II trial

Laufend - Rekrutierung – beendet · 2021 bis 2099